Open Orphan To Relist On AIM Following hVIVO All-Share Merger
Open Orphan To Relist On AIM Following hVIVO All-Share Merger
Read moreOpen Orphan To Relist On AIM Following hVIVO All-Share Merger
Read moreOpen Orphan Meets Acceptance Condition For Merger With hVIVO
Read more(Sharecast News) - Open Orphan, the rare and orphan drug services company, has agreed the takeover of hVIVO by means of an all-share reverse take-over at a 33.8% premium.
Read moreAIM-Listed Firms Open Orphan And hVIVO Set For Tie-Up
Read more(Alliance News) - hVivo PLC is targeting a profit by 2020, it said on Thursday, with a strong pipeline of work opportunities lying ahead.hVivo, which provides clinical development services,
Read moreFriday 13 September JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment
Read more(Alliance News) - Induction Healthcare Group PLC said Friday it has appointed Shelley Fraser as chief financial officer on an interim basis with immediate effect.She will be replacing Seb a
Read more(Alliance News) - Clinical development firm hVIVO PLC said on Tuesday that it has completed the respiratory syncytial virus human challenge study on 60-75 year-old adults for positive tests found
Read more(Alliance News) - Clinical development firm hVivo PLC on Wednesday said it is to start a new anti-mosquito trial, while its finance chief has also left.hVivo is to start a trial at the of a
Read more(Alliance News) - hVIVO PLC on Tuesday said Jupiter Asset Management Ltd now holds an 11% stake in the scientific research company.Prior to this transaction on Monday, Jupiter's if any,
Read moreFriday 24 MayPageGroupOld MutualFevertree GroupMonday 27 events 28 Stobart 29
Read moreLONDON (Alliance News) - hVIVO PLC on Thursday described 2018 as a "transitional" year as it posted a widened annual loss on impairment charges.For 2018, the drug discovery posted
Read more(Sharecast News) - Clinical development services company hVIVO announced positive results for the primary endpoint, following completion of analysis of samples by NIAID, and additional results from the Phase IIb viral challenge study of FLU-v.
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.5%. The supermarket chain revealed a a
Read moreLONDON (Alliance News) - hVIVO PLC on Thursday said it achieved the primary endpoint in a phase II study of FLU-v, a vaccine candidate for influenza.The company said that the study showed a
Read more